CY1114168T1 - ANTI-CULTURAL CONFIGURATION OF EXPRESSION OF APLIPPROTEIN B - Google Patents

ANTI-CULTURAL CONFIGURATION OF EXPRESSION OF APLIPPROTEIN B

Info

Publication number
CY1114168T1
CY1114168T1 CY20131100628T CY131100628T CY1114168T1 CY 1114168 T1 CY1114168 T1 CY 1114168T1 CY 20131100628 T CY20131100628 T CY 20131100628T CY 131100628 T CY131100628 T CY 131100628T CY 1114168 T1 CY1114168 T1 CY 1114168T1
Authority
CY
Cyprus
Prior art keywords
expression
aplipprotein
cultural
configuration
apolipoprotein
Prior art date
Application number
CY20131100628T
Other languages
Greek (el)
Inventor
Rosanne Crooke
Mark Graham
Kristina Lemonidis-Tarbet
Kenneth W Dobie
Susan M Freier
Original Assignee
Genzyme Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10180483.9A external-priority patent/EP2336318B1/en
Application filed by Genzyme Corporation filed Critical Genzyme Corporation
Publication of CY1114168T1 publication Critical patent/CY1114168T1/en

Links

Abstract

Παρέχονται αντιπληροφοριακές ενώσεις, συνθέσεις και μέθοδοι για τη διαμόρφωση της έκφρασης της απολιποπρωτεΐνης Β. Οι συνθέσεις περιλαμβάνουν αντιπληροφοριακές ενώσεις, ιδίως αντιπληροφοριακά ολιγονουκλεοτίδια, στοχευμένες σε νουκλεϊκά οξέα που κωδικοποιούν την απολιποπρωτεΐνη Β. Παρέχονται μέθοδοι χρήσης αυτών των ενώσεων για τη διαμόρφωση της έκφρασης της απολιποπρωτεΐνης Β και για τη θεραπευτική αντιμετώπιση νόσων που σχετίζονται με την έκφραση της απολιποπρωτεΐνης Β.Antisense compounds, compositions and methods for modulating apolipoprotein B expression are provided. The compositions comprise antisense compounds, in particular antisense oligonucleotides, targeted to nucleic acids encoding apolipoprotein B expression for their use in the method B provided. and for the treatment of diseases related to the expression of apolipoprotein B.

CY20131100628T 2002-11-13 2013-07-24 ANTI-CULTURAL CONFIGURATION OF EXPRESSION OF APLIPPROTEIN B CY1114168T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42623402A 2002-11-13 2002-11-13
EP10180483.9A EP2336318B1 (en) 2002-11-13 2003-11-13 Antisense modulation of apolipoprotein b expression

Publications (1)

Publication Number Publication Date
CY1114168T1 true CY1114168T1 (en) 2016-08-31

Family

ID=58436314

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20131100628T CY1114168T1 (en) 2002-11-13 2013-07-24 ANTI-CULTURAL CONFIGURATION OF EXPRESSION OF APLIPPROTEIN B
CY20131100675T CY1114199T1 (en) 2002-11-13 2013-08-08 ANTI-CULTURAL CONFIGURATION OF EXPRESSION OF APLIPPROTEIN B

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20131100675T CY1114199T1 (en) 2002-11-13 2013-08-08 ANTI-CULTURAL CONFIGURATION OF EXPRESSION OF APLIPPROTEIN B

Country Status (1)

Country Link
CY (2) CY1114168T1 (en)

Also Published As

Publication number Publication date
CY1114199T1 (en) 2016-08-31

Similar Documents

Publication Publication Date Title
CY1116385T1 (en) ANTIMONATIC CONFIGURATION OF EXPRESSION OF APLIPOPROTEIN B
CY1124931T1 (en) TREATMENT OF PHENYL KETONOURIA WITH BH4
CY1110177T1 (en) Z-CARBONYLSYL SUBSTITUTED BISINSULARS AS RAF MOTION INHIBITORS
CY1110633T1 (en) AMENDMENT OF THE SURBIVIN EXPRESSION CONTRACT
ATE496127T1 (en) ANTISENSE MODULATION OF CLUSTERINE EXPRESSION
WO2004044181A3 (en) Antisense modulation of apolipoprotein b expression
CY1114443T1 (en) INDIVIDUAL THERAPEUTIC USEFUL IN TREATMENT OF ADDITIONAL DISORDERS
CY1115059T1 (en) THERAPEUTIC APPARATUS USEFUL IN THE THERAPEUTIC TREATMENT OF SUPPLEMENTARY DISORDERS
CY1115580T1 (en) COMPOSITION AND ANTI-VIVAL ACTIVITY OF SUBSTITUTED AZAIDOLOLOXIC Piperazine Derivatives
CY1111225T1 (en) NEW Peptides As NS3-Serine Protease Inhibitors Inhibit C
WO2003097662A8 (en) Antisense modulation of apolipoprotein b expression
NO20084738L (en) Compounds and Methods for Modulating the Expression of PCSK9
DK1250455T3 (en) Antisense inhibition of PTP1B expression
CY1105286T1 (en) O-CARBOXYARYLYPOsubstituted BINYLUREAS AS RAF KINASE INHIBITORS
CY1106386T1 (en) SUBSTITUTED 3-PYRROLIDINE-INDOLE DERIVATIVES
CY1111499T1 (en) COMPOSITIONS AND METHODS FOR THE THERAPEUTIC USE OF A TREATMENT WITH ATONAL SEQUENCE
CY1113116T1 (en) Substituted 4-Aminocyclohexanols
CY1109361T1 (en) Substituted 4-Aminocyclohexanols
DK1123414T3 (en) Antisense modulation of integrin alpha 4. expression
WO2003105755A3 (en) Antisense modulation of vegf-c expression
HUP0402327A2 (en) Antisense modulation of insulin-like growth factor binding protein 5 expression
WO2004021978A3 (en) Antisense modulation of endothelial specific molecule 1 expression
CY1114199T1 (en) ANTI-CULTURAL CONFIGURATION OF EXPRESSION OF APLIPPROTEIN B
DE602004001047D1 (en) Phospholipid ester of clofarabine
BRPI0411168A (en) hair treatment composition, uses of a hair treatment composition and method